Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05385536 · ClinicalTrials.gov registry record
Evaluating UTI Outcomes in at Risk Populations
A clinical trial, sponsored by Pathnostics.
- Completed
- Registry status
- 7,921
- Enrollment target
NCT05385536 is a clinical trial that has completed, run by Pathnostics. The registered enrollment target is 7,921 participants.
The verdict
NCT05385536 has completed, sponsored by Pathnostics.
- COMPLETED
- Registry status
- 7,921 participants
- Enrollment target
Study Summary
This is a multicenter, observational comparative cohort, study to evaluate the UTI related adverse event rates between Guidance® UTI clinical pathway versus the current traditional clinical pathways for urine testing.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7,921 participants |
| Start Date | 2022-07-18 |
| Est. Completion | 2024-03-29 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05385536
The ClinicalTrials.gov registry entry for NCT05385536 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 7,921 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pathnostics, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT05385536 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05385536 about?
NCT05385536 is a clinical study titled "Evaluating UTI Outcomes in at Risk Populations". This is a multicenter, observational comparative cohort, study to evaluate the UTI related adverse event rates between Guidance® UTI clinical pathway versus the current traditional clinical pathways for urine testing.
What is the current status of trial NCT05385536?
This trial is currently completed. The enrollment target is 7,921 participants. The study started on 2022-07-18. Estimated completion is 2024-03-29.
Who is sponsoring clinical trial NCT05385536?
This trial is sponsored by Pathnostics, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.